EDMONTON, Alberta--(BUSINESS WIRE)--Laboratorios León Farma SA has agreed to settle a class action in which it is alleged that certain packages of the prescription oral contraceptive, Alysena™ 28, contained an insufficient number of active tablets such that, when used as directed, Alysena™ 28 did not perform its intended contraceptive function. Some class members allege to have had unintended pregnancies, for which they claim various losses including pain and suffering relating to pregnancy, the costs of raising children, and loss of mobility.
The settlement seeks to resolve the claims of women who used Alysena™ 28 that was purchased in Canada between November 19th, 2012 and April 15th, 2013, and the biological fathers of children born to these women after those dates. Packages of Alysena™ 28, which allegedly may have been defective, were recalled in April of 2013.
The settlement must be approved to be binding, and a hearing will be held at the Court of Queen’s Bench of Alberta in Edmonton on December 1st, 2015, to permit class members to voice any objections to the settlement.
Additional information about the potential compensatory benefits to be paid under the settlement and how class members may participate in or exclude themselves from the class action may be obtained at www.alysena28classaction.com or by contacting the Court-appointed notice administrator at:
Trilogy Class Action Services